USPTO Issues Notice of Allowance for IRLAB Drug Candidate Patent
The USPTO issued a notice of allowance for a patent covering IRLAB Therapeutics’ drug candidate IRL1117.
The USPTO issued a notice of allowance for a patent covering IRLAB Therapeutics’ drug candidate IRL1117.